S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,492.00 +0.93%
Next Bullish Trade
Sign in
BAYRY

Bayer Aktiengesellschaft OQX · BAYRY

$13.80 +0.20 (+1.47%)
Extended · +1.34σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · BAYRY

Momentum reads · latest daily bar
Last
$13.80
+0.20 (+1.47%)
Mkt cap
$54.2B
Healthcare
RSI(14)
61.7
neutral
Stochastic %K
41.6
neutral
MFI(14)
40.1
neutral
ADX(14)
31.5
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $13.4B $2.8B $3.5B $-2.2B 20.6% 26.3%
2025-12-31 $11.4B $-3.8B $4.3B $3.4B -32.8% 38.0%
2025-09-30 $9.7B $-1.0B $-0.5B $0.8B -10.0% -5.6%
2025-06-30 $10.7B $-0.2B $0.0B $0.6B -1.9% 0.1%
2025-03-31 $13.7B $1.3B $2.3B $-1.4B 9.5% 16.9%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare BAYRY vs peers

Line BAYRY up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing BAYRY MSFT× AVGO× MRK× GOOG×
Sector peers + LLY + UNH + JNJ + ABBV + PFE + TMO
Popular + AAPL + NVDA + AMZN + META + TSLA
Verdict
Weighted score 0-100 across 5 tickers · best in green
#2
BAYRY
score 55.5
5/5 inputs
Dominates with momentum=94 from 32.95% one-month surge but sentiment=7 heavily drags overall score to second place.
value 93growth 50quality 0momentum 94sentiment 7
#5
MSFT
score 32.1
3/5 inputs
Momentum=5 from negative 16.73% YTD collapse severely limits score despite sentiment=76 from 20% insider buying.
quality 25momentum 5sentiment 76
#4
AVGO
score 43.5
5/5 inputs
Quality=84 with 76.28% gross margin offsets value=17 penalty from 61.5 trailing PE, ranking fourth overall.
value 17growth 50quality 84momentum 21sentiment 67
#3
MRK
score 49.4
5/5 inputs
Momentum=76 from 19.77% YTD performance balances growth=15 weakness, placing third with forward PE of 13.2.
value 62growth 15quality 51momentum 76sentiment 49
#1
GOOG
score 66.7
2/5 inputs
Quality=100 delivers highest overall score despite limited data, with momentum=42 from 9.77% YTD gain providing support.
quality 100momentum 42
BAYRY
Bayer Aktiengesellschaft
$13.80
+1.47%
Snapshot
Price 13.8
Day % 1.47
1M % 32.95
3M % 16.95
YTD % 24.44
Market cap 54229807104.0
ADV ($) 19244983.465991974
Beta 0.83
OdysseyHQ zone
Current zone Extended
Dist 21-EMA % 4.01
Dist ATR (σ) 1.34
OdysseyHQ grade
Confluence 1
Valuation
P/E (ttm)
P/E (fwd) 11.139633
P/S 1.1986607
EV/EBITDA 8.523
P/B 1.6485983
FCF yield 0.1349
PEG 4.61
Growth
Revenue yoy -0.024
EPS yoy 1.129
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.59918
Operating margin 0.26319
Net margin -0.04765
ROE -0.06928
ROA 0.03637
Debt / Equity 1.34
Interest cov. -0.38
Technicals
RSI(14) 61.7
MACD signal neutral
vs 50-DMA 17.38
vs 200-DMA 26.78
vs 52w high -9.39
HV-30 59.0
Sentiment
Analyst rec 2.25
Target upside 10.33
Insider buy-sell 90d
Risk
Short interest
Days to cover 0.0
Next earnings 2026-08-04
Full BAYRY dashboard →
MSFT
MSFT
$393.82
-1.82%
Snapshot
Price 393.82
Day % -1.82
1M % -0.0
3M % -6.29
YTD % -16.73
Market cap
ADV ($)
Beta
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 1.16
Dist ATR (σ) 0.37
OdysseyHQ grade
Confluence 0
Valuation
P/E (ttm)
P/E (fwd)
P/S
EV/EBITDA
P/B
FCF yield
PEG
Growth
Revenue yoy
EPS yoy
FCF yoy
Revenue trend 8Q
Quality
Gross margin
Operating margin
Net margin
ROE
ROA
Debt / Equity
Interest cov. 52.84
Technicals
RSI(14) 51.9
MACD signal neutral
vs 50-DMA -1.92
vs 200-DMA -10.36
vs 52w high -29.1
HV-30 34.3
Sentiment
Analyst rec
Target upside
Insider buy-sell 90d 20
Risk
Short interest
Days to cover
Next earnings
Full MSFT dashboard →
AVGO
Broadcom Inc.
$370.83
-0.97%
Snapshot
Price 370.83
Day % -0.97
1M % -1.56
3M % -6.94
YTD % 6.68
Market cap 1764229775360.0
ADV ($) 9734209227.586304
Beta 1.462
OdysseyHQ zone
Current zone Pullback
Dist 21-EMA % -3.79
Dist ATR (σ) -0.84
OdysseyHQ grade
Confluence 2
Valuation
P/E (ttm) 61.496685
P/E (fwd) 19.098053
P/S 23.37812
EV/EBITDA 43.407
P/B 20.120728
FCF yield 0.0154
PEG 0.44
Growth
Revenue yoy 0.479
EPS yoy 0.854
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.76284
Operating margin 0.48988
Net margin 0.38848
ROE 0.37280998
ROA 0.121190004
Debt / Equity 0.74
Interest cov. 8.08
Technicals
RSI(14) 43.8
MACD signal neutral
vs 50-DMA -7.97
vs 200-DMA 1.98
vs 52w high -25.09
HV-30 66.2
Sentiment
Analyst rec 1.3125
Target upside 41.44
Insider buy-sell 90d -43
Risk
Short interest 1.5
Days to cover 1.9
Next earnings 2026-09-03
Full AVGO dashboard →
MRK
MRK
$127.50
-0.10%
Snapshot
Price 127.5
Day % -0.1
1M % 10.71
3M % 10.43
YTD % 19.77
Market cap 314902609920.0
ADV ($) 1319581140.0
Beta 0.205
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 2.82
Dist ATR (σ) 0.96
OdysseyHQ grade B
Confluence 3
Valuation
P/E (ttm) 36.01695
P/E (fwd) 13.203829
P/S 4.7880826
EV/EBITDA 12.141
P/B 6.863695
FCF yield 0.0446
PEG 11.81
Growth
Revenue yoy 0.049
EPS yoy
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.76725996
Operating margin 0.38604
Net margin 0.13586001
ROE 0.18944
ROA 0.12578
Debt / Equity 1.07
Interest cov. 16.52
Technicals
RSI(14) 57.9
MACD signal neutral
vs 50-DMA 6.67
vs 200-DMA 16.44
vs 52w high -3.22
HV-30 33.7
Sentiment
Analyst rec 1.82143
Target upside 5.13
Insider buy-sell 90d 40
Risk
Short interest 1.27
Days to cover 2.48
Next earnings 2026-08-04
Full MRK dashboard →
GOOG
GOOG
$346.12
-2.17%
Snapshot
Price 346.12
Day % -2.17
1M % -6.73
3M % 4.01
YTD % 9.77
Market cap
ADV ($)
Beta
OdysseyHQ zone
Current zone Pullback
Dist 21-EMA % -3.01
Dist ATR (σ) -0.94
OdysseyHQ grade C
Confluence 3
Valuation
P/E (ttm)
P/E (fwd)
P/S
EV/EBITDA
P/B
FCF yield
PEG
Growth
Revenue yoy
EPS yoy
FCF yoy
Revenue trend 8Q
Quality
Gross margin
Operating margin
Net margin
ROE
ROA
Debt / Equity
Interest cov. 216.8
Technicals
RSI(14) 43.3
MACD signal neutral
vs 50-DMA -5.94
vs 200-DMA 7.84
vs 52w high -14.43
HV-30 36.1
Sentiment
Analyst rec
Target upside
Insider buy-sell 90d
Risk
Short interest
Days to cover
Next earnings
Full GOOG dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-11 0.79 0.62 +29.1% +3.0%
2026-03-03 0.18 0.16 +13.5% +0.4%
2025-11-11 0.17 0.13 +30.9% +5.7%
2025-08-06 0.36 0.25 +43.4% +2.1%
2025-05-13 0.70 0.69 +0.4% -10.0%
2025-03-04 0.28 0.26 +4.8% +6.5%
2024-11-12 0.06 0.17 -62.1% -3.9%
2024-08-06 0.26 0.25 +1.2% +1.0%
2024-05-12 0.76 0.42 +80.1% +1.3%
2024-03-04 0.50 0.45 +10.6% -7.7%
2023-11-08 0.10 0.27 -62.7% +0.2%
2023-08-08 0.34 0.31 +6.6% -0.3%
2023-05-11 0.81 0.54 +48.7% +0.0%
2023-02-28 0.36 0.33 +8.6% +1.1%
2022-11-08 0.28 0.22 +29.5% -3.8%
2022-08-04 0.49 0.50 -1.9% -7.1%
2022-05-10 0.93 0.77 +21.0% -8.0%
2022-03-01 0.35 0.27 +32.8% +3.9%
2021-11-09 0.30 0.30 +0.6% +0.1%
2021-08-05 0.48 0.47 +2.2% +0.2%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
BAYRY $54B 11.1 1.2 8.5 1.6 59.9% -2.4% 112.9% 13.49%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0%
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 0.17%

HolderShares% out
Kahn Brothers Group Inc. 6,513,893 0.17%
Westside Investment Management, Inc. 2,878
PNC Financial Services Group, Inc. 3,030
Atlas Capital Advisors Inc 35,510
Great Lakes Advisors LLC 119,517
Rhumbline Advisers 68,123
Salomon & Ludwin, LLC 2,141
Gamma Investing LLC 41,204
Chicago Trust Co Na 20,097
Sterling Capital Management, LLC 846

Insider activity · 90d

No insider trades for BAYRY in last 90d.

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$14.5
Mean
$15.225
High
$15.8
Analysts
4
Recommendation distribution · period 2026-07-01
6
15
7
Revision trend (2026-04-01 → 2026-07-01): net 19 → 21 +2 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

No CIK found for BAYRY.

About BAYRY

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmaci…

Options picks · BAYRY

ITM + OTM ideas from the latest scan

Loading…

Congress trades · BAYRY

STOCK Act disclosures

Loading…

SEC filings & insiders · BAYRY

EDGAR · live

Loading…

Holders · BAYRY

Institutions & insider activity

Loading…